BioVision, Inc.

13 articles about BioVision, Inc.

• Abcam completes $340m strategic acquisition and expands kit capacity and capability

  10/27/2021

  Abcam, a global innovator in life sciences reagents and tools, announces the successful completion of its acquisition of BioVision and the expansion of its immunoassay capacity in Eugene, OR.

• Abcam to Acquire BioVision for $340 million

  8/2/2021

  Abcam plc, a global leader in the supply of life science research tools, announces that it has entered into a definitive agreement to acquire BioVision, Inc., a wholly owned subsidiary of Boai NKY Medical Holdings Ltd., for $340 million.

• BioVision, Inc.: Fifty Promising Life Sciences Start-Ups And Projects Selected For April 15 And 16

  3/26/2015

• BioVision, Inc. 2015: 50 Experts Discuss Global Healthcare And Personalized Medicine

  3/5/2015

• BioVision, Inc. Announces The Winners Of The Catalyzer And Investor Conference Awards

  6/11/2014

• BioVision, Inc. Presents Its Selection Of 44 Promising Life Sciences Businesses And Projects

  5/19/2014

• BioVision, Inc. Will Explore Ways To Identify And Fund Disruptive Innovation In Healthcare – June 5 And 6, 2014

  2/10/2014

• BioVision, Inc. Announces the Winners of the 2011 Biovision -Lilly Award, in Conjunction with TWAS

  4/12/2011

• The 7th Edition of BioVision, the World Life Sciences Forum Opens in Lyon

  3/23/2011

• BioVision, Inc. Obtains the International Year of Chemistry Label (IYC 2011)

  1/12/2011

• BioVision, Inc., the World Life Sciences Forum, Emphasises Economic Considerations in its 7th Meeting

  12/20/2010

• BioVision, Inc. and the Lilly MDR-TB Partnership Create an Award for Young Scientists, in Conjunction with TWAS, the Academy of Sciences for the Developing World

  12/7/2010

• BioVision, Inc. Aquires BioVisioN AG To Develop Disease Management Solutions

  2/27/2006